Zero2IPO FOF is China's trust worthy platform for FOF equity investment and asset allocation, relying on in-depth research, understanding and practice of China's angel investment, venture capital and private equity markets, and based on extensive contacts and resources in the industry and excellent FOF management team.
Zero2IPO FOF currently manages nine FOFs. It has obtained investments from well-known organizations such as Tsinghua University Education Foundation, Yangtze River Industry Fund, Xiamen Jinyuan Investment Group, Haier Group and Bank of Hangzhou. At present, it has completed investments in more than 80 sub-funds and projects and 10 enterprises invested have successfully listed.
Intco Medical Products(300677.SZ) invested by sub-fund Yunqi Partners got listed on SZSE ChiNext.
Qudian Inc.(NYSE:QD) invested by sub-fund BlunRun Ventures got listed on NYSE.
NIU Technologies (NASDAQ:NIU) invested by sub-fund PlumVentures got listed on NASDAQ.
360 Finance Inc.(NASDAQ:QFIN) invested by sub-fund Yunqi Partners got listed on NASDAQ.
Cansino Biologics Inc.(HKG:6185) invested by sub-fund Fortune Capital got listed on HKEX.
Raytron Technology invested by sub-fund Tsinghua Holdings Capital got listed on STAR Market.